Monday, October 26, 2026
19 C
Bengaluru

What will Pharma of the Future Look Like?

In a recent MedicinMan Poll on LinkedIn, it was clear that pharma field forces have hit a brick wall. Other than GPs, very few specialist doctors seem interested in meeting Medical Reps.

This is in keeping with the trends in the US and European markets, where Medical Reps meet with doctors only three or four times a year. If this is the case in markets where innovative molecules are available, it is not surprising that doctors in India are not keen on meeting with Medical Reps once a month, let alone twice a month just to be reminded of branded generic names. As if doctors have some memory problems!

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

China’s Biopharma Strategy: A Warning and Opportunity for India

China is playing a long game in biopharma. And...

Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.

With over two decades of experience across finance, strategy,...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Topics

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Who Profits From Trust?

Indian healthcare does not suffer from a shortage of...
spot_img

Related Articles

spot_imgspot_img